Reducing Hereditary Cancer Act

HR 4752, the Reducing Hereditary Cancer Act, requires Medicare to cover genetic testing for germline mutations in individuals with a family history of hereditary cancer or suspicious personal/family history. It mandates coverage for risk-reducing surgeries (like mastectomies or hysterectomies) when guided by evidence-based clinical guidelines, and increases the frequency of cancer screenings (such as mammograms, colonoscopies, and breast MRI) for Medicare beneficiaries confirmed to have hereditary cancer gene mutations - ensuring screenings occur at least annually. The bill applies to Medicare beneficiaries with specific high-risk profiles, aligning coverage with guidelines from recognized oncology organizations like the National Comprehensive Cancer Network. It does not change eligibility but modifies Medicare’s existing coverage rules to expand access to these preventive services.